Genetics, Muscular dystrophy, Internal medicine, Duchenne muscular dystrophy and Dystrophin are his primary areas of study. His study looks at the intersection of Genetics and topics like Congenital myopathy with RYR1 and Myopathy. Volker Straub has researched Muscular dystrophy in several fields, including Limb-girdle muscular dystrophy, Molecular biology and Gene, Exon.
His Internal medicine research is multidisciplinary, relying on both Gastroenterology, Endocrinology and Surgery. In his research on the topic of Duchenne muscular dystrophy, Drisapersen is strongly related with Eteplirsen. His Dystrophin study combines topics from a wide range of disciplines, such as ITGA7 and Cell biology.
His main research concerns Muscular dystrophy, Internal medicine, Duchenne muscular dystrophy, Pathology and Genetics. While the research belongs to areas of Muscular dystrophy, Volker Straub spends his time largely on the problem of Limb-girdle muscular dystrophy, intersecting his research to questions surrounding Anatomy. His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology, Endocrinology and Cardiology.
His Duchenne muscular dystrophy research focuses on subjects like Clinical trial, which are linked to Disease. His study in Pathology is interdisciplinary in nature, drawing from both Exome sequencing and Weakness. His Dystrophin research includes elements of Exon skipping and Morpholino.
His primary areas of investigation include Internal medicine, Duchenne muscular dystrophy, Muscular dystrophy, Pathology and Myopathy. His studies in Internal medicine integrate themes in fields like Gastroenterology and Endocrinology. His studies deal with areas such as Clinical trial and Oncology as well as Duchenne muscular dystrophy.
His study on Muscular dystrophy also encompasses disciplines like
Volker Straub spends much of his time researching Muscular dystrophy, Internal medicine, Duchenne muscular dystrophy, Clinical trial and Skeletal muscle. Volker Straub has included themes like Missense mutation, Loss function, Phenotype, Frameshift mutation and Limb-girdle muscular dystrophy in his Muscular dystrophy study. The Limb-girdle muscular dystrophy study combines topics in areas such as Muscle biopsy and Cohort.
Much of his study explores Internal medicine relationship to Endocrinology. His work on Dystrophin as part of general Duchenne muscular dystrophy research is frequently linked to Rasch model, bridging the gap between disciplines. The study incorporates disciplines such as Magnetic resonance imaging, Muscle weakness and Pathology in addition to Skeletal muscle.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy
Richard S. Finkel;Eugenio Mercuri;Basil T. Darras;Anne M. Connolly.
The New England Journal of Medicine (2017)
Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study.
Sebahattin Cirak;Virginia Arechavala-Gomeza;Michela Guglieri;Lucy Feng.
The Lancet (2011)
Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study
Maria Kinali;Maria Kinali;Virginia Arechavala-Gomeza;Lucy Feng;Sebahattin Cirak.
Lancet Neurology (2009)
Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies
Daniel E. Michele;Rita Barresi;Motoi Kanagawa;Fumiaki Saito.
Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1.
Aruto Yoshida;Kazuhiro Kobayashi;Hiroshi Manya;Kiyomi Taniguchi.
Developmental Cell (2001)
The Human Phenotype Ontology in 2017
Sebastian Köhler;Nicole A. Vasilevsky;Mark Engelstad;Erin D. Foster.
Nucleic Acids Research (2017)
Animal models for muscular dystrophy show different patterns of sarcolemmal disruption
Volker Straub;Jill A. Rafael;Jeffrey S. Chamberlain;Kevin P. Campbell.
Journal of Cell Biology (1997)
A Phase I/II trial of MYO-029 in Adult Subjects with Muscular Dystrophy
Kathryn R. Wagner;James L. Fleckenstein;Anthony A. Amato;Richard J. Barohn.
Annals of Neurology (2008)
Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C
Martin Brockington;Yeliz Yuva;Paola Prandini;Susan C. Brown.
Human Molecular Genetics (2001)
Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population
Fiona L. M. Norwood;Chris Harling;Patrick F. Chinnery;Michelle Eagle.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: